ONGAVIA Trademark

Trademark Overview


On Thursday, March 17, 2016, a trademark application was filed for ONGAVIA with the United States Patent and Trademark Office. The USPTO has given the ONGAVIA trademark a serial number of 86944227. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 12, 2018. This trademark is owned by Warner Chilcott Company, LLC. The ONGAVIA trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals a...
ongavia

General Information


Serial Number86944227
Word MarkONGAVIA
Filing DateThursday, March 17, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 12, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWarner Chilcott Company, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFajardo 00738
PR

Party NameWarner Chilcott Company, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFajardo 00738
PR

Trademark Events


Event DateEvent Description
Thursday, December 13, 2018UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, November 13, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 12, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 11, 2018EXTENSION 3 GRANTED
Wednesday, April 11, 2018EXTENSION 3 FILED
Monday, June 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 24, 2018UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, May 15, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 16, 2018ASSIGNED TO EXAMINER
Tuesday, May 15, 2018NOTICE OF REVIVAL - E-MAILED
Tuesday, May 15, 2018EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, May 15, 2018PETITION TO REVIVE-GRANTED
Tuesday, May 15, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, May 14, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 14, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 26, 2017EXTENSION 2 GRANTED
Tuesday, September 26, 2017EXTENSION 2 FILED
Tuesday, September 26, 2017TEAS EXTENSION RECEIVED
Wednesday, April 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 3, 2017EXTENSION 1 GRANTED
Monday, April 3, 2017EXTENSION 1 FILED
Monday, April 3, 2017TEAS EXTENSION RECEIVED
Tuesday, October 11, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 27, 2016ASSIGNED TO EXAMINER
Tuesday, March 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 21, 2016NEW APPLICATION ENTERED IN TRAM